Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Renovo is a biopharmaceutical product company and is the world leader in scar prevention and reduction research, and the development of drugs to prevent and reduce scarring. The Company has a highly skilled management team with over 30 years of research in the field of scarring, and significant pharmaceutical industry experience. Renovo has a portfolio of drugs which exploit different novel mechanisms of action to prevent and reduce scarring at multiple body sites and to accelerate healing. The Company’s deep pipeline includes four drugs in phase II clinical development, a further four advanced pre-clinical candidates and nine other pre-clinical ( www.renovo.com )
Renovo Ltd
The Manchester Incubator Building 48 Grafton Street
Manchester, M13 9XX
United Kingdom
Tel: +44 161 606 7328
Fax: +44 161 606 7333